https://repertaxininhibitor.co....m/modified-pectoral-
A risk assessment tool was constructed and validated, using variables observed on the first day of hospitalization in the 2017-2018 cohort and an independent 2019 cohort. The model's clinical value was underscored by examining the association between predicted risk and therapy use patterns within the validation cohort. A study group composed of 5542 patients, having a median age of 76 years and 48% identifying as female, sh
Мне нравится
Комментарий
Перепост
